Journal of the American College of CardiologyVeerakul, G, Chaothawee, L, Koananatakul, B (2002) Ajmaline versus procainamide challenge test in the diagnosis of sudden unexplained death or Brugada syndrome. J Am Coll Cardiol 39: pp. 112A-3
Brugada syndrome: insights of ST elevation, arrhythmogenicity, and risk stratification from experimental observations. Heart Rhythm 2009;6(suppl 11):S34–S43. 14. Wolpert C, Echternach C, Veltmann C, et al. Intravenous drug challenge using flecainide and ajmaline in patients with ...
78 The basis for SCB challenge for the diagnosis of BrS originates from Miyazaki et al,90 who systematically examined the effects of various antiarrhythmic medications in patients with BrS and found that class 1a antiarrhythmic drugs (procainamide or disopyramide in their study) augmented the ...
New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives. Eur Heart J. 2001 December;22(24):2290-2296. Article PubMed CAS Google Scholar Miyamoto K, Yokokawa M, Tanaka K, et al. Diagnostic...
Patients with Brugada syndrome (BrS) may experience recurrent ventricular arrhythmias (VAs). Catheter ablation is becoming an emerging paradigm for treatment of BrS. Objective To assess the efficacy and safety of catheter ablation in BrS in an updated systematic review. Methods We comprehensively search...
His electrocardiogram (ECG) showed interventricular conduction delay and underwent a procainamide challenge that did not show the Brugada pattern. However, his genetic test showed an SCN5A mutation c.5219 C>T (p. Ser1710l_eu) and was diagnosed with Brugada syndrome. His daughter was diagnosed ...
The subsequent electrophysiology shows no induced ventricular arrhythmias while a procainamide challenge test reveals the dynamic induction of type-I Brugada syndrome. The patient was given an implantable cardioverter defibrillator due to the findings and his family history of recurrent syncope and ...
Intravenous infusion of sodium-channel blockers (SCB) with either ajmaline, flecainide, procainamide, or pilsicainide to unmask the ECG of Brugada syndrome is the drug challenge most commonly used for diagnostic purposes when investigating cases possibly related to inherited arrhythmia syndromes. For ...
This may be spontaneous or after provocation challenge with intravenous administration of a sodium channel blocker (i.e. ajmaline, flecainide, procainamide or pilsicainide). The specific protocol for ajmaline provocation challenge for diagnosis of BrS has been debated between ICC services worldwide. ...
New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives Eur Heart J, 22 (2001), pp. 2290-2296 CrossrefView in ScopusGoogle Scholar 22 K. Matsuo, T. Kurita, M. Inagaki, et al. The circa...